RxDoctor Payments Data

Matthew Mead, MD

Adult Reconstructive Orthopaedic Surgery · Petoskey, MINPI 1659721926

Payments from drug & device makers

What this record shows

This record is dominated by education: $16,355 of the $23,364 with a category attached, or 70.0%. Smith+Nephew accounts for 72.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $10,678 and has fallen 94.6% since, to $582 in 2025.

$23,364in general payments, 2019–2025

Across 71 payments — averaging $329.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$17K
  • Stryker$3K
  • Medical Device Business Services, Inc.$1K
  • Zimmer Biomet$709
  • Davol Inc.$298
  • Medwest Associates$269
  • plus $641 from 9 others

What the payments were for

  • Travel & lodging$3,22514%
  • Food & beverage$3,78416%
  • Education$16,35570%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,364 in reported general payments places this provider in the 65th percentile of 35 adult reconstructive orthopaedic surgery providers in Michigan.

See all adult reconstructive orthopaedic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$115,228
Medicare patients
104
Services billed
574

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam113$803
Mupirocin54$321
Oxycodone Hcl33$118
Methylprednisolone12$79
Tramadol Hcl34$77
Gabapentin15$43

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Petoskey

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →